Drug companies do not want to market bad drugs and balance the risk of premature release against the benefits, so market incentives already discipline quality, making the government's extra screening less necessary.
causalpending
Speaker
Sam PeltzmanEvidence Quote
“they don't want to market bad drugs per se”
Created: 11/11/2026, 5:13:30 AM
Your notes
Loading notes...